At the news
? NEUTRALIMPACT 3/10 144 filed Jun 29, 2026 at 09:05 ET
Eric Warren, an officer of Mineralys Therapeutics, filed a Form 144 notice of intent to sell 104,124 shares of common stock, with an approximate market value of $2.7 million based on the filing date. The shares were acquired via a cashless exercise of employee stock options on June 26, 2026. This is a routine insider sale by an officer, not a transformative event, and the filing signals intent to sell, not a completed transaction.
- Filer: Eric Warren, an officer of Mineralys Therapeutics
- Shares to be sold: 104,124 shares of common stock
- Approximate market value: $2,696,321.98 (based on filing date price of ~$25.90/share)
- Acquisition: Shares acquired via cashless exercise of employee stock options on June 26, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access